Back
Plus Therapeutics Stock Predictions
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
25
PSTV
Plus Therapeutics
Last Price:
$1.08
Seasonality Move:
5.93%
7 Day Trial
ALL ACCESS PASS
$
7
2025 Gold Forecast: A Perfect Storm for Demand
Discover our Gold Price Outlook for 2025--FREE--herePlus Therapeutics Stock Forecast
-
Is Plus Therapeutics Stock Undervalued?The current Plus Therapeutics [PSTV] share price is $1.08. The Score for PSTV is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
-
PSTV is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
Will Plus Therapeutics Stock Go Up Next Year?
Data Unavailable
Plus Therapeutics Stock Rating
Data Unavailable
Plus Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
plustherapeutics.com
52-Week Data
52-Week High:
2.67
52-Week Low:
0.93
Prediction Charts
Market Cap:
6.4M
Price in USD:
1.08
Volume:
7K
Beta:
1.29
Technical Analysis
SMA50:
1.28
SMA100:
1.37
SMA200:
1.63
52-Wk Change:
-43.46%
Stock Predictions
-
Is Plus Therapeutics stock public?Yes, Plus Therapeutics is a publicly traded company.
-
What is the Plus Therapeutics stock quote today?The Plus Therapeutics stock price is 1.08 USD today.
-
How to buy Plus Therapeutics stock online?You can buy Plus Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Dec-5 | 1.36 | 1.34 | 1.40 | 1.31 |
| Dec-6 | 1.38 | 1.39 | 1.45 | 1.32 |
| Dec-9 | 1.38 | 1.35 | 1.41 | 1.33 |
| Dec-10 | 1.34 | 1.31 | 1.36 | 1.30 |
| Dec-11 | 1.36 | 1.35 | 1.36 | 1.30 |
| Dec-12 | 1.36 | 1.33 | 1.37 | 1.26 |
| Dec-13 | 1.31 | 1.27 | 1.33 | 1.22 |
| Dec-16 | 1.28 | 1.17 | 1.28 | 1.12 |
| Dec-17 | 1.21 | 1.07 | 1.23 | 1.03 |
| Dec-18 | 1.07 | 1.00 | 1.10 | 0.98 |
| Dec-19 | 1.01 | 0.99 | 1.10 | 0.93 |
| Dec-20 | 1.01 | 1.09 | 1.11 | 0.97 |
| Dec-23 | 1.14 | 1.07 | 1.14 | 1.03 |
| Dec-24 | 1.07 | 1.08 | 1.11 | 1.07 |
Plus Therapeutics Earnings
Data Unavailable
Plus Therapeutics Forecast Revenue Growth
Data Unavailable
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.80 per share, and a decrease next year of $0.04 per share.
* Plus Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.